Olema Pharmaceuticals

OLMA · NASDAQ

$7.25+$0.14 (+1.97%)TodayMarket closed ·
Prev close $7.11

Who owns OLMA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 66.9% of OLMA’s shares.

  • Fidelity Management & Research Company LLC10.1%
  • Paradigm BioCapital Advisors LP9.9%
  • Janus Henderson Investors8.1%
  • Bain Capital Life Sciences Investors, LLC8.1%
  • Next 6 largest institutions30.7%
  • All other shareholders33.1%
Top institutional holders of OLMA
HolderShares% of shares
Fidelity Management & Research Company LLC8.79M10.06%
Paradigm BioCapital Advisors LP8.67M9.93%
Janus Henderson Investors7.09M8.12%
Bain Capital Life Sciences Investors, LLC7.09M8.11%
BlackRock Institutional Trust Company, N.A.5.76M6.59%
BVF Partners L.P.5.30M6.06%
Invus Public Equities Advisors, LLC4.86M5.56%
State Street Investment Management (US)4.32M4.94%
Vanguard Capital Management, LLC3.34M3.83%
Logos Global Management LP3.21M3.67%

Largest mutual fund holders

Top mutual fund holders of OLMA
HolderShares% of shares
State Street SPDR S&P Biotech ETF2.87M3.28%
Vanguard Total Stock Market Index Fund2.61M2.99%
iShares Russell 2000 ETF2.04M2.33%
Fidelity Select Health Care Portfolio1.68M1.92%
Fidelity Strategic Advisers Fidelity US Total Stk1.42M1.63%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $291.16K (2 trades) of OLMA on the open market, with no buys.

Latest OLMA insider transactions
InsiderTypeSharesValue
O'Byrne JasonAward650.00K—
Harmon CyrusSale12.50K$146.42K
Harmon CyrusSale12.50K$144.74K
Raman PrakashAward29.50K—
Harmon CyrusAward29.50K—
Hrustanovic GorjanAward29.50K—
Larson YiAward29.50K—
Graham G. WalmsleyAward29.50K—
Horning SandraAward29.50K—
Garland J. ScottAward29.50K—

Short interest

Settled Sep 30, 2026

Shares short
14.70M
Days to cover
10.19
% of shares outstanding
16.82%
Average daily volume
1.44M
Change since last report
−8.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.